N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide

C28H37NO10S — CID 59466682

IUPACN-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide
SMILESCOCOc1cc2oc(CNS(C)(=O)=O)cc2c2c1C(=O)O[C@@H](C)[C@H](C)/C=C\C(O)[C@H]1OC(C)(C)O[C@H]1C/C=C/2
InChIInChI=1S/C28H37NO10S/c1-16-10-11-21(30)26-22(38-28(3,4)39-26)9-7-8-19-20-12-18(14-29-40(6,32)33)37-23(20)13-24(35-15-34-5)25(19)27(31)36-17(16)2/h7-8,10-13,16-17,21-22,26,29-30H,9,14-15H2,1-6H3/b8-7+,11-10-/t16-,17+,21?,22+,26-/m1/s1
InChIKeyWEGWNWQBXRNHPX-ZHSXJGQDSA-N
MW579.67 g/mol
LogP3.50
Rot. Bonds6

About N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide

N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide (PubChem CID 59466682) has the molecular formula C28H37NO10S and a molecular weight of 579.67 g/mol. Its IUPAC name is N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide.

Molecular Properties

Compound NameN-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide
PubChem CID59466682
Molecular FormulaC28H37NO10S
Molecular Weight579.67 g/mol
Exact Mass579.21
IUPAC NameN-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide
SMILESCOCOc1cc2oc(CNS(C)(=O)=O)cc2c2c1C(=O)O[C@@H](C)[C@H](C)/C=C\C(O)[C@H]1OC(C)(C)O[C@H]1C/C=C/2
InChIInChI=1S/C28H37NO10S/c1-16-10-11-21(30)26-22(38-28(3,4)39-26)9-7-8-19-20-12-18(14-29-40(6,32)33)37-23(20)13-24(35-15-34-5)25(19)27(31)36-17(16)2/h7-8,10-13,16-17,21-22,26,29-30H,9,14-15H2,1-6H3/b8-7+,11-10-/t16-,17+,21?,22+,26-/m1/s1
InChIKeyWEGWNWQBXRNHPX-ZHSXJGQDSA-N
XLogP3.50
TPSA142.76 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds6
Heavy Atoms40
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500579.67
LogP ≤ 53.50
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide?
The IUPAC name of N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide (CID 59466682) is N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide.
What is the SMILES notation for N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide?
The canonical SMILES for N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide is COCOc1cc2oc(CNS(C)(=O)=O)cc2c2c1C(=O)O[C@@H](C)[C@H](C)/C=C\C(O)[C@H]1OC(C)(C)O[C@H]1C/C=C/2.
What is the InChIKey of N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide?
The InChIKey is WEGWNWQBXRNHPX-ZHSXJGQDSA-N. The full InChI is InChI=1S/C28H37NO10S/c1-16-10-11-21(30)26-22(38-28(3,4)39-26)9-7-8-19-20-12-18(14-29-40(6,32)33)37-23(20)13-24(35-15-34-5)25(19)27(31)36-17(16)2/h7-8,10-13,16-17,21-22,26,29-30H,9,14-15H2,1-6H3/b8-7+,11-10-/t16-,17+,21?,22+,26-/m1/s1.
What are the key properties of N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide?
N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide has a molecular weight of 579.67 g/mol, XLogP of 3.50, 6 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[(2E,5S,9R,11Z,13R,14S)-10-hydroxy-18-(methoxymethoxy)-7,7,13,14-tetramethyl-16-oxo-6,8,15,21-tetraoxatetracyclo[15.7.0.05,9.020,24]tetracosa-1(24),2,11,17,19,22-hexaen-22-yl]methyl]methanesulfonamide is sourced from PubChem (CID 59466682), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).